Penn Medicine’s Center for Cellular Immunotherapies (CCI) is at the forefront of revolutionizing cancer treatment through CAR (chimeric antigen receptor) T cell therapy. This innovative approach harnesses the power of the patient’s own immune system to target and destroy cancer cells, offering new
Randomized controlled trials (RCTs) are widely recognized as the gold standard for evaluating the efficacy of interventions. In the context of HIV research in Africa, multicenter RCTs are particularly valuable due to the diverse socio-cultural and geographical settings. This scoping review aims to
The landscape of clinical trials is on the brink of a significant transformation, driven by the integration of Real World Data (RWD). By 2025, the use of RWD is expected to revolutionize the way clinical trials are conducted, offering new opportunities for efficiency, accuracy, and patient-centric
Recent advancements in imaging technology have caused a significant shift in how high-risk nonmetastatic hormone-sensitive prostate cancer is staged. Conventional imaging techniques, which have long been the standard, might have significantly underestimated the extent of metastasis in these
Acute respiratory infections are a significant cause of both morbidity and mortality in young children globally, with an especially pronounced impact in low- and middle-income countries on children under five years old. Among the array of pathogens responsible for these illnesses, human
In a transformative study examining the impact of GLP-1 receptor agonist drugs on post-surgical outcomes for diabetic patients, researchers have discovered significant reductions in post-surgical complications when these medications are part of the regimen. Drugs like tirzepatide and semaglutide,
